Showing 261-270 of 8349 results for "".
Checkpoint Blockade for Advanced cSCC: Exploring Newer Options
https://practicaldermatology.com/topics/skin-cancer-photoprotection/checkpoint-blockade-for-advanced-cscc-exploring-newer-options/23487/Two newer systemic options on the market provide hope in the fight against advanced cutaneous squamous cell carcinoma.Eczema Discovery; Ortho Dermatologics, Revision, Alastin Product Launches
https://practicaldermatology.com/topics/practice-management/dermwiretv-eczema-discovery-ortho-dermatologics-revision-alastin-product-launches/18353/Regeneron revealed that Dupixent generated sales of $120M within the first nine months of launch. Researchers have identified a possible treatment for moderate-to-severe atopic dermatitis: IL-22 blockade. Product launches or updates from Revision Skincare, Alastin Skincare, Ortho Dermatologics, andBUSINESS ADVISOR: The Just-in-Time Model: Smart Inventory Management in Tough Economic Times
https://practicaldermatology.com/topics/general-topics/the-just-in-time-model-smart-inventory-management-in-tough-economic-times/21963/Meeting inventory challenges can help control costs and ensure consistent cash flow during economic difficulties.Microwave Technology Offers a New Approach to Excessive Sweating
https://practicaldermatology.com/topics/rare-disease/microwave-technology-offers-a-new-approach-to-excessive-sweating/22960/A new device offers a long-term solution to excessive sweating.What to Know About PA Education and Dermatology Training
https://practicaldermatology.com/topics/general-topics/what-to-know-about-pa-education-and-dermatology-training/21643/Part II of a series highlights key considerations regarding the education and training of PAs in dermatology.DWTV Extra: Phase 3 Data on Roflumilast for AD, PsO
https://practicaldermatology.com/series/dermwire-tv/dwtv-extra-phase-3-data-on-roflumilast-for-ad-pso/35925/Study investigator Melinda Gooderham, MD, talks about the Phase 3 trials of roflumilast cream 0.15% for adults and children down to age 6 with atopic dermatitis and roflumilast foam 0.3% for patients older than 12 with psoriasis of the scalp and body.Ask an Expert: What is the Role of Dermatology Hospitalists?
https://practicaldermatology.com/topics/general-topics/ask-an-expert-april-2019/19599/Helena Pasieka, MD, MS talks to host Adam Friedman, MD about the important role dermatologists can play in supporting patient care in the hospital setting. Consulting dermatologists in the hospital setting change the diagnosis up to 50% of the time!Micromanagement: Microparticles Enhance Outcomes of Energy-based Acne Care
https://practicaldermatology.com/topics/general-topics/micromanagement-microparticles-enhance-outcomes-of-energy-based-acne-care/20384/With recent FDA-clearance, microparticles are available to support Nd:YAG based treatment of inflammatory acne.Set Appropriate Expectations
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/set-appropriate-expectations/19039/Proper expectations are essential to patient satisfaction when providing cosmetic procedures.Systemic Effects of UV Radiation: The Case for Apoptosis of Peripheral Blood Mononuclear Cells
https://practicaldermatology.com/topics/general-topics/PD0709_11-php/22806/Mechanisms of UV-mediated tumorigenesis and development are not fully understood. Findings suggest apoptosis of peripheral blood mononuclear cells may play a role.